Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India

Clin Microbiol Infect. 2017 Dec;23(12):1005-1006. doi: 10.1016/j.cmi.2017.06.019. Epub 2017 Jun 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Cholera / drug therapy
  • Cholera / epidemiology
  • Cholera / microbiology
  • Cholera Toxin / genetics
  • Ciprofloxacin / pharmacology*
  • Ciprofloxacin / therapeutic use
  • DNA Gyrase / genetics
  • DNA Topoisomerase IV / genetics
  • Drug Resistance, Bacterial / genetics
  • Genetic Variation / drug effects*
  • Genotype*
  • Humans
  • India / epidemiology
  • Models, Molecular
  • Vibrio cholerae O1 / drug effects
  • Vibrio cholerae O1 / genetics*
  • Vibrio cholerae O1 / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Cholera Toxin
  • DNA Topoisomerase IV
  • DNA Gyrase